4-(2-MORPHOLIN-4-YL-THIAZOL-4-YL)-PHENYLAMINE
![]() |
- $312 - $1109
- Product name: 4-(2-MORPHOLIN-4-YL-THIAZOL-4-YL)-PHENYLAMINE
- CAS: 883545-59-3
- MF: C13H15N3OS
- MW: 261.34
- EINECS:
- MDL Number:MFCD06660602
- Synonyms:4-(2-MORPHOLIN-4-YL-THIAZOL-4-YL)-PHENYLAMINE;[4-(2-morpholin-4-yl-1,3-thiazol-4-yl)phenyl]amine;[4-(2-morpholinothiazol-4-yl)phenyl]amine;4-(2-morpholin-4-yl-1,3-thiazol-4-yl)aniline;4-(2-morpholino-4-thiazolyl)aniline;4-(2-morpholinothiazol-4-yl)aniline;Benzenamine, 4-[2-(4-morpholinyl)-4-thiazolyl]-
4 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
Package
- 250mg
- 1g
- 2.5g
- 5g
- ManufacturerAK Scientific
- Product number1716AF
- Product description4-(2-Morpholin-4-yl-thiazol-4-yl)-phenylamine
- Packaging250mg
- Price$312
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number1716AF
- Product description4-(2-Morpholin-4-yl-thiazol-4-yl)-phenylamine
- Packaging2.5g
- Price$1109
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11034508
- Product description[4-(2-morpholin-4-yl-1,3-thiazol-4-yl)phenyl]amine 95+%
- Packaging5g
- Price$752
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number020819
- Product description4-(2-Morpholin-4-yl-thiazol-4-yl)-phenylamine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 1716AF | 4-(2-Morpholin-4-yl-thiazol-4-yl)-phenylamine | 250mg | $312 | 2021-12-16 | Buy |
AK Scientific | 1716AF | 4-(2-Morpholin-4-yl-thiazol-4-yl)-phenylamine | 2.5g | $1109 | 2021-12-16 | Buy |
Crysdot | CD11034508 | [4-(2-morpholin-4-yl-1,3-thiazol-4-yl)phenyl]amine 95+% | 5g | $752 | 2021-12-16 | Buy |
Matrix Scientific | 020819 | 4-(2-Morpholin-4-yl-thiazol-4-yl)-phenylamine | 1g | $378 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|